Skip to main content

Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001659323

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Iterum Therapeutics plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−2 vs. Q1 2022
Shares held
5.89M
+786.9K (+15.4%) vs. Q1 2022
Total value
$1.18M
−$628.4K (−34.8%) vs. Q1 2022
New holders
7
4 more added
Sold out
9
6 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 39 institutions
Q1 2021: 50 institutionsQ2 2021: 45 institutionsQ3 2021: 42 institutionsQ4 2021: 45 institutionsQ1 2022: 41 institutionsQ2 2022: 39 institutionsQ3 2022: 25 institutionsQ4 2022: 23 institutionsQ1 2023: 17 institutionsQ2 2023: 17 institutionsQ3 2023: 15 institutionsQ4 2023: 16 institutionsQ1 2024: 18 institutionsQ2 2024: 15 institutionsQ3 2024: 18 institutionsQ4 2024: 24 institutionsQ1 2025: 20 institutionsQ2 2025: 24 institutionsQ3 2025: 24 institutionsQ4 2025: 20 institutionsQ1 2026: 18 institutionsQ2 2026: 2 institutions
Value heldQ2 2022: $1.18M
Q1 2021: $11.2MQ2 2021: $26.0MQ3 2021: $3.45MQ4 2021: $2.57MQ1 2022: $1.80MQ2 2022: $1.18MQ3 2022: $575.4KQ4 2022: $243.7KQ1 2023: $187.3KQ2 2023: $393.4KQ3 2023: $184.0KQ4 2023: $761.6KQ1 2024: $1.43MQ2 2024: $494.7KQ3 2024: $2.22MQ4 2024: $2.18MQ1 2025: $1.38MQ2 2025: $2.38MQ3 2025: $904.1KQ4 2025: $557.9KQ1 2026: $41.3KQ2 2026: $542
Institutions holding ITRM and their total value by quarter
QuarterHoldersValue
Q2 20262$542
Q1 202618$41.3K
Q4 202520$557.9K
Q3 202524$904.1K
Q2 202524$2.38M
Q1 202520$1.38M
Q4 202424$2.18M
Q3 202418$2.22M
Q2 202415$494.7K
Q1 202418$1.43M
Q4 202316$761.6K
Q3 202315$184.0K
Q2 202317$393.4K
Q1 202317$187.3K
Q4 202223$243.7K
Q3 202225$575.4K
Q2 202239$1.18M
Q1 202241$1.80M
Q4 202145$2.57M
Q3 202142$3.45M
Q2 202145$26.0M
Q1 202150$11.2M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q1 2022.

Institutions holding ITRM in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG1$00.00%−29,484−100.0%Reduced
Howe & Rusling Inc500$00.00%00.0%Unchanged
National Bank of Canada36$00.00%00.0%Unchanged
HM Payson & Co50$00.00%00.0%Unchanged
Blue Bell Private Wealth Management, LLC1,000$00.00%00.0%Unchanged
Ancora Advisors, LLC578$00.00%00.0%Unchanged
Captrust Financial Advisors500$00.00%00.0%Unchanged
Cypress Capital Management LLC (WY)1,000$00.00%00.0%Unchanged
Larson Financial Group LLC200$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,280$00.00%00.0%Unchanged
Kelly Financial Services LLC1,800$3600.00%00.0%Unchanged
American Portfolios Advisors2,000$4000.00%00.0%Unchanged
Wells Fargo & Company4,585$1.00K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.6,500$1.00K0.00%00.0%Unchanged
Creative Financial Designs Inc8,000$2.00K0.00%+8,000New
Resources Investment Advisors, LLC.16,556$3.00K0.00%00.0%Unchanged
Savant Capital, LLC13,888$3.00K0.00%00.0%Unchanged
Geneos Wealth Management Inc.20,000$4.00K0.00%00.0%Unchanged
Principle Wealth Partners LLC30,000$6.00K0.00%+30,000New
Jane Street Group, LLC37,235$7.00K0.00%+37,235New
Citigroup Inc40,000$8.00K0.00%+38,700+2,976.9%Added
Squarepoint Ops LLC44,442$9.00K0.00%−120−0.3%Reduced
Brown Advisory Inc60,000$12.0K0.00%00.0%Unchanged
Geode Capital Management, LLC92,095$18.0K0.00%00.0%Unchanged
Millennium Management LLC88,101$18.0K0.00%+88,101New
Edmond de Rothschild Holding S.A.100,000$20.0K0.00%00.0%Unchanged
Focused Wealth Management, Inc105,000$21.0K0.00%+5,000+5.0%Added
Virtu Financial LLC110,470$22.0K0.00%−172,371−60.9%Reduced
Verition Fund Management LLC112,500$23.0K0.00%00.0%Unchanged
Grimes & Company, Inc.179,396$36.0K0.00%+3,120+1.8%Added
Krilogy Financial LLC200,000$40.0K0.00%+200,000New
Morgan Stanley221,207$44.0K0.00%−5,023−2.2%Reduced
Franklin Resources Inc258,778$52.0K0.00%−125,422−32.6%Reduced
Goldman Sachs Group Inc304,684$61.0K0.00%+304,684New
Gsa Capital Partners LLP304,684$61.0K0.01%+304,684New
Renaissance Technologies LLC323,300$65.0K0.00%+215,200+199.1%Added
New Leaf Venture Partners, L.L.C.1,456,303$292.0K0.19%00.0%Unchanged
Canaan Partners X LLC1,733,170$346.0K0.60%00.0%Unchanged
IFP Advisors, Inc6,000––−2,000−25.0%Reduced
Citadel Advisors LLC0$00.00%−50,515−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−29,292−100.0%Sold out
LPL Financial LLC0$00.00%−14,000−100.0%Sold out
Sigma Planning Corp0$00.00%−11,500−100.0%Sold out
Koshinski Asset Management, Inc.0$00.00%−5,000−100.0%Sold out
US Bancorp0$00.00%−2,000−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−388−100.0%Sold out
Bollard Group LLC0$00.00%−724−100.0%Sold out
Bedel Financial Consulting, Inc.0$00.00%−20−100.0%Sold out